NENZA Trademark
Trademark Overview
On Tuesday, July 9, 2002, a trademark application was filed for NENZA with the United States Patent and Trademark Office. The USPTO has given the NENZA trademark a serial number of 78142219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, April 2, 2004. This trademark is owned by Pfizer Inc.. The NENZA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
General Information
| Serial Number | 78142219 |
| Word Mark | NENZA |
| Filing Date | Tuesday, July 9, 2002 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, April 2, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 7, 2003 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 12, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Tuesday, July 6, 2004 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, August 27, 2003 | EXTENSION 1 GRANTED |
| Thursday, August 14, 2003 | EXTENSION 1 FILED |
| Thursday, August 14, 2003 | TEAS EXTENSION RECEIVED |
| Tuesday, April 1, 2003 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 7, 2003 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 18, 2002 | NOTICE OF PUBLICATION |
| Monday, November 4, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 30, 2002 | EXAMINER'S AMENDMENT MAILED |
| Wednesday, October 23, 2002 | ASSIGNED TO EXAMINER |
